Search
Myriad Genetics Inc
MYGNAdd to Watchlist
5.920USD
-0.370-5.88%
Close 11-06 16:00（ET）
566.25MMarket Cap
LossP/E TTM
Today
-5.88%
5 Days
-6.77%
1 Month
+40.95%
6 Months
+38.00%
Year to Date
-3.74%
1 Year
-6.03%
Key Figures
6.210Open
6.360High
363.95KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.38%Turnover Ratio
6.290Prev. Close
5.895Low
2.19MTurnover
LossP/E Static
2.11P/B
0.00%Div Yield TTM
-47.61%ROA
8.09052wk High
0.17Volume Ratio
-127.30MNet Profit
95.65MShares
-4.3142EPS TTM
1.77Beta
-76.73%ROE
2.74052wk Low
13.51%Amplitude
67.75%Gross Margin
566.25MMarket Cap
-12.73Reward/Risk
5.33%Risk Rate
Myriad Genetics Inc's Score
-0.08vs previous score
Forecast5.56
Financial Health6.51
Technical6.01
Valuation Dimensions7.63
Institutional Confidence10.00
Risk Assessment3.69
Media Coverage
Coverage Level
Very Low
Very High
Positive+
Analyst Rating
Myriad Genetics Inc Technical Analysis
Technical Indicators
Sell
Summary
Neutral
Moving Average
Buy
Myriad Genetics Inc Latest Earnings Call Transcripts
Myriad Genetics (MYGN) Q3 2026 Earnings Call: Guidance Raised, Prenatal Sale
Myriad Genetics Q3 2026 revenue reached $202.7 million as margins improved, guidance rose and the company agreed to sell Prenatal Health for $210 million.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.46/-0.20
Revenue / Forecast
202.70M/191.33M
Myriad Genetics Inc Profile
SectorHealthcare Equipment & Supplies
Ticker SymbolMYGN
Number of employees2700
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 14.46% |
| Millennium Management LLC | 7.09% |
| Glenview Capital Management, LLC | 5.23% |
| D. E. Shaw & Co., L.P. | 4.77% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 36.83% |
| Investment Advisor/Hedge Fund | 28.26% |
| Hedge Fund | 27.45% |
| Research Firm | 6.06% |
Related Instruments
-0.40%
+2.63%
-3.23%
+1.73%
-3.36%
-2.90%
-2.75%
+3.10%
-2.46%
-1.48%
-2.62%
-1.80%
-4.23%
+1.31%
-0.78%
+0.79%
-0.30%
+5.33%
+1.73%
-2.05%Popular Instruments
51920.500
+629.900 (+1.23%)
27206.200
+241.700 (+0.90%)
7440.400
+60.400 (+0.82%)
12797.000
-1.000 (-0.01%)
59193.000
+1051.000 (+1.81%)
6265.200
+124.600 (+2.03%)
86.062
-3.795 (-4.22%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4122.040
+56.370 (+1.39%)
FAQs
What is the current price of Myriad Genetics Inc (MYGN)?
The current price of Myriad Genetics Inc (MYGN) is 5.92.
What is the symbol of Myriad Genetics Inc?
The ticker symbol of Myriad Genetics Inc is MYGN.
What is the 52-week high of Myriad Genetics Inc?
The 52-week high of Myriad Genetics Inc is 8.09.
What is the 52-week low of Myriad Genetics Inc?
The 52-week low of Myriad Genetics Inc is 2.74.
What is the market capitalization of Myriad Genetics Inc?
The market capitalization of Myriad Genetics Inc is 566.25M.
Is Myriad Genetics Inc (MYGN) currently rated as Buy, Hold, or Sell?
According to analysts, Myriad Genetics Inc (MYGN) has an overall rating of signal_hold, with a price target of 4.49.
What is the Earnings Per Share (EPS TTM) of Myriad Genetics Inc (MYGN)?
The Earnings Per Share (EPS TTM) of Myriad Genetics Inc (MYGN) is -4.31.